Back
NeuroPace, Inc. Stock Price Chart
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
69
NPCE
NeuroPace, Inc.
Last Price:
$16.73
Seasonality Move:
1.13%
7 Day Trial
ALL ACCESS PASS
$
7
99.6% Win Rate Across 508 Picks (Third-Party Audited)
See how Decentralized Masters' system identifies 10x-100x opportunities before Coinbase. Watch free training.-
The current trend is moderately bullish and NPCE is experiencing selling pressure, which indicates risk of future bearish movement.
NeuroPace, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.82 | Buy |
| 20-day SMA: | 16.45 | Buy |
| 50-day SMA: | 15.71 | Buy |
| 200-day SMA: | 12.06 | Buy |
| 8-day EMA: | 16.82 | Buy |
| 20-day EMA: | 16.51 | Buy |
| 50-day EMA: | 15.4 | Buy |
| 200-day EMA: | 12.62 | Buy |
NeuroPace, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.39 | Buy |
| Relative Strength Index (14 RSI): | 57.94 | Buy |
| Chaikin Money Flow: | -93691 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
NeuroPace, Inc. Technical Analysis
| Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for NeuroPace, Inc. Stock
Is NeuroPace, Inc. Stock a Buy?
-
NeuroPace, Inc. share price is 17.04 while NPCE 8-day simple moving average is 16.82, which is a Buy signal.
-
The stock price of NPCE is 17.04 while NeuroPace, Inc. 20-day SMA is 16.45, which makes it a Buy.
-
NeuroPace, Inc. 50-day simple moving average is 15.71 while NPCE share price is 17.04, making it a Buy technically.
-
NPCE stock price is 17.04 and NeuroPace, Inc. 200-day simple moving average is 12.06, creating a Buy signal.
NPCE Technical Analysis vs Fundamental Analysis
Buy
69
NeuroPace, Inc. (NPCE)
is a Buy
Is NeuroPace, Inc. a Buy or a Sell?
-
NeuroPace, Inc. stock is rated a BuyThe current NeuroPace, Inc. [NPCE] share price is $17.04. The Score for NPCE is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
NeuroPace, Inc. Stock Info
Market Cap:
566.9M
Price in USD:
17.04
Share Volume:
114.5K
NeuroPace, Inc. 52-Week Range
52-Week High:
18.98
52-Week Low:
7.56
Buy
69
NeuroPace, Inc. (NPCE)
is a Buy
NeuroPace, Inc. Share Price Forecast
-
What is the NeuroPace, Inc. stock price today?The NeuroPace, Inc. stock price is 17.04 USD today.
-
Will NPCE stock go up or go down?NeuroPace, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is NeuroPace, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, NeuroPace, Inc. is not overvalued.
Is NeuroPace, Inc. Stock a Buy?
-
NeuroPace, Inc. share price is 17.04 while NPCE 8-day exponential moving average is 16.82, which is a Buy signal.
-
The stock price of NPCE is 17.04 while NeuroPace, Inc. 20-day EMA is 16.51, which makes it a Buy.
-
NeuroPace, Inc. 50-day exponential moving average is 15.40 while NPCE share price is 17.04, making it a Buy technically.
-
NPCE stock price is 17.04 and NeuroPace, Inc. 200-day simple moving average is 12.62, creating a Buy signal.
Fundamental Analysis of NeuroPace, Inc.
Is NeuroPace, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.32 per share.
Technical Analysis of NeuroPace, Inc.
Should I short NeuroPace, Inc. stock?
-
NPCE Moving Average Covergence Divergence (MACD) indicator is 0.39, suggesting NeuroPace, Inc. is a Buy
-
NeuroPace, Inc. Relative Strength Index (RSI) is 57.94, which suggest NeuroPace, Inc. is overbought
-
The Bollinger Bands (25) for NeuroPace, Inc. is ( - ), which suggest NeuroPace, Inc. is a Buy
-
The Bollinger Bands (100) for NeuroPace, Inc. is ( - ), which suggest NeuroPace, Inc. is a Buy
* NeuroPace, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.